Cell Therapeutics Inc. Newsletter
-
Lineage Cell to Evaluate Novel Delivery of OPC1 Cell Therapy for Spinal Cord Injury
25 Apr 2024 13:43 GMT
The FDA has cleared Lineage Cell Therapeutics’ investigational new drug (IND) amendment … Cord Injury. News release. Lineage Cell Therapeutics. February 13, 2024.
-
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
17 Apr 2024 00:22 GMT
… developer of adult stem cell therapeutics for neurodegenerative diseases, … quot;
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is … autologous adult stem cell therapeutics for debilitating neurodegenerative diseases …
-
BrainStorm Cell Therapeutics Regains Compliance with NASDAQ Minimum Market Value Rule - April 11, 2024
11 Apr 2024 15:58 GMT
… Rule.
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is a … innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. … -302114212.html
SOURCE BrainStorm Cell Therapeutics Inc.
Company Codes: …
-
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS
10 Apr 2024 13:38 GMT
… Executive Officer of BrainStorm Cell Therapeutics, added: "Biomarkers … ALS.
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is a … innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. …
-
BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
09 Apr 2024 14:00 GMT
… developer of adult stem cell therapeutics for neurodegenerative diseases, … 7270
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is a … innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. …
-
BrainStorm Cell Therapeutics to Provide Update on NurOwn Program
08 Apr 2024 12:06 GMT
… -7270
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is a … innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. … -302110266.html
SOURCE BrainStorm Cell Therapeutics Inc.
Company Codes: …
-
BrainStorm Cell Therapeutics Announces Full Year 2023 Financial Results and Provides Corporate Update
01 Apr 2024 18:59 GMT
… .
About BrainStorm Cell Therapeutics Inc.
BrainStorm Cell Therapeutics Inc. is … autologous adult stem cell therapeutics for debilitating neurodegenerative … statements.
BRAINSTORM CELL THERAPEUTICS INC.
CONSOLIDATED STATEMENTS OF …
-
NKGen Biotech Announces Upcoming Publication at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
24 Apr 2024 20:45 GMT
… CAR-NK natural killer (“NK”) cell therapeutics, today announced an online publication … , allogeneic, and CAR-NK NK cell therapeutics. NKGen is headquartered in Santa …
-
Lineage Cell Therapeutics : Immediate Report
24 Mar 2024 10:06 GMT
… undersigned hereunto duly authorized.
Lineage Cell Therapeutics, Inc.
Date:
March 22 … 10171
Ladies and Gentlemen:
Lineage Cell Therapeutics, Inc., a California corporation … Document
Permalink
Disclaimer
Lineage Cell Therapeutics Inc. published this content …
-
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium
18 Mar 2024 12:31 GMT
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: … -225-0292.
About Lineage Cell Therapeutics, Inc.
Lineage Cell Therapeutics is a clinical-stage …